Synkrino Biotherapeutics YC Application
Synkrino Biotherapeutics went through Y Combinator in the Summer 2018 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Summer 2018
- Industry
- HealthcareDrug Discovery and Delivery
- Team size
- 2
- Status
- Active
- Launched
- 2018
Founders
Jason BarbourFounder/CEO
David OttFounder/CTO
Synkrino Biotherapeutics's YC application, reconstructed
Y Combinator application
Synkrino Biotherapeutics, Summer 2018 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Synkrino Biotherapeutics
AI system for unbiased drug discovery
We're building SATIS, an AI-powered platform that discovers new drug candidates without human bias in the early discovery process. SATIS analyzes complex biological data to identify novel therapeutic compounds more efficiently than traditional methods.
We live in Oakland, CA, and plan to keep the company based there after YC.
Oakland allows us to stay close to biotech hubs in the Bay Area while maintaining a strong startup community and affordable workspace compared to San Francisco.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Synkrino Biotherapeutics YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Synkrino Biotherapeutics's public data (launch notes, founder backgrounds, product description). It shows how a company like Synkrino Biotherapeutics would present itself to YC, not the text they submitted.
What YC batch was Synkrino Biotherapeutics in?
Synkrino Biotherapeutics was part of the Y Combinator Summer 2018 batch.
Who founded Synkrino Biotherapeutics?
Synkrino Biotherapeutics was founded by Jason Barbour, David Ott.
What does Synkrino Biotherapeutics do?
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Synkrino Biotherapeutics's application, and every other YC batch, is in YC Insights.
More YC startups like Synkrino Biotherapeutics
